论文部分内容阅读
目的 探讨经皮穿剌瘤体内注射碘油 +无水乙醇治疗巨块型肝癌的疗效。方法 对 2 0例经临床及病理证实为原发性肝细胞癌 (巨块型 )的患者行彩超引导下经皮穿剌瘤体内注射碘油 +无水乙醇 ,并进行生存期及生存质量的随访。结果 2 0例患者的 1、2年生存率分别为 60 %、35 % ,生存质量高。结论 对于不能手术切除的巨块型肝癌 ,采用经皮穿剌瘤体内注射碘油 +无水乙醇的方法进行治疗 ,其疗效肯定 ,操作简单、安全方便 ,费用低 ,患者易接受 ,值得基层医院推广、应用。
Objective To investigate the efficacy of percutaneous puncture in vivo injection of lipiodol + ethanol in the treatment of massive liver cancer. Methods Twenty cases of primary hepatocellular carcinoma (massive type) confirmed clinically and pathologically underwent ultrasonography and percutaneous transdermal instillation of lipiodol plus absolute ethanol, and their survival and quality of life Follow-up. Results The 1-year and 2-year survival rates of 20 patients were 60% and 35% respectively, and the quality of life was high. CONCLUSIONS: For the massive liver cancer that can not be surgically resected, percutaneous transdermal intratumoral injection of lipiodol + absolute ethanol is the most effective method for the treatment of giant hepatocellular carcinoma. The curative effect is definite, the operation is simple, the safety is convenient, the cost is low and the patients are easy to accept. Promote, application.